File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.tiv.2003.12.010
- Scopus: eid_2-s2.0-2342593351
- PMID: 15130601
- WOS: WOS:000222155000006
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Chloramphenicol succinate, a competitive substrate and inhibitor of succinate dehydrogenase: Possible reason for its toxicity
Title | Chloramphenicol succinate, a competitive substrate and inhibitor of succinate dehydrogenase: Possible reason for its toxicity |
---|---|
Authors | |
Keywords | Chloramphenicol succinate Human bone marrow and liver Metabolism Rat liver and kidney mitochondria Succinate dehydrogenase |
Issue Date | 2004 |
Publisher | Pergamon. The Journal's web site is located at http://www.elsevier.com/locate/toxinvit |
Citation | Toxicology In Vitro, 2004, v. 18 n. 4, p. 441-447 How to Cite? |
Abstract | From our previous study [Eur. J. Clin. Pharmacol. 56 (2000) 405] we hypothesized that chloramphenicol succinate (CAPS) may be a competitive substrate for succinate dehydrogenase (SDH). It may be oxidized by SDH to release chloramphenicol (CAP), which may inhibit SDH by feed back mechanism. The present ex-vivo/in vitro study was aimed to investigate this possibility by using human tissues (bone marrow and liver samples) and animal tissues (rat liver and kidney). The effect of different SDH activators and specific inhibitors was studied on CAPS metabolism by SDH. The metabolites and reduction products were detected by using HPLC. In marrow samples, CAPS was slowly oxidized to form CAP. The formation of CAP (oxidation product) was enhanced by FAD and low malonate and inhibited by high malonate and 3-NPA. Similar results were obtained with mitochondria from human and rat tissues. These studies suggest that CAPS could be a competitive oxidative substrate and the metabolite CAP could be an inhibitor at the reduction site. Therefore, SDH could be a target molecule responsible for CAPS induced toxicity. © 2004 Elsevier Ltd. All rights reserved. |
Persistent Identifier | http://hdl.handle.net/10722/91592 |
ISSN | 2023 Impact Factor: 2.6 2023 SCImago Journal Rankings: 0.656 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ambekar, CS | en_HK |
dc.contributor.author | Lee, JSK | en_HK |
dc.contributor.author | Cheung, BMY | en_HK |
dc.contributor.author | Chan, LC | en_HK |
dc.contributor.author | Liang, R | en_HK |
dc.contributor.author | Kumana, CR | en_HK |
dc.date.accessioned | 2010-09-17T10:21:52Z | - |
dc.date.available | 2010-09-17T10:21:52Z | - |
dc.date.issued | 2004 | en_HK |
dc.identifier.citation | Toxicology In Vitro, 2004, v. 18 n. 4, p. 441-447 | en_HK |
dc.identifier.issn | 0887-2333 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/91592 | - |
dc.description.abstract | From our previous study [Eur. J. Clin. Pharmacol. 56 (2000) 405] we hypothesized that chloramphenicol succinate (CAPS) may be a competitive substrate for succinate dehydrogenase (SDH). It may be oxidized by SDH to release chloramphenicol (CAP), which may inhibit SDH by feed back mechanism. The present ex-vivo/in vitro study was aimed to investigate this possibility by using human tissues (bone marrow and liver samples) and animal tissues (rat liver and kidney). The effect of different SDH activators and specific inhibitors was studied on CAPS metabolism by SDH. The metabolites and reduction products were detected by using HPLC. In marrow samples, CAPS was slowly oxidized to form CAP. The formation of CAP (oxidation product) was enhanced by FAD and low malonate and inhibited by high malonate and 3-NPA. Similar results were obtained with mitochondria from human and rat tissues. These studies suggest that CAPS could be a competitive oxidative substrate and the metabolite CAP could be an inhibitor at the reduction site. Therefore, SDH could be a target molecule responsible for CAPS induced toxicity. © 2004 Elsevier Ltd. All rights reserved. | en_HK |
dc.language | eng | en_HK |
dc.publisher | Pergamon. The Journal's web site is located at http://www.elsevier.com/locate/toxinvit | en_HK |
dc.relation.ispartof | Toxicology in Vitro | en_HK |
dc.subject | Chloramphenicol succinate | en_HK |
dc.subject | Human bone marrow and liver | en_HK |
dc.subject | Metabolism | en_HK |
dc.subject | Rat liver and kidney mitochondria | en_HK |
dc.subject | Succinate dehydrogenase | en_HK |
dc.subject.mesh | Animals | en_HK |
dc.subject.mesh | Bone Marrow - drug effects - physiology | en_HK |
dc.subject.mesh | Chloramphenicol - analogs & derivatives - analysis - pharmacology - toxicity | en_HK |
dc.subject.mesh | Chromatography, High Pressure Liquid | en_HK |
dc.subject.mesh | Humans | en_HK |
dc.subject.mesh | Kidney - drug effects - physiology | en_HK |
dc.subject.mesh | Liver - drug effects - physiology | en_HK |
dc.subject.mesh | Mitochondria - drug effects - physiology | en_HK |
dc.subject.mesh | Oxidation-Reduction | en_HK |
dc.subject.mesh | Oxidative Stress | en_HK |
dc.subject.mesh | Protein Synthesis Inhibitors - analysis | en_HK |
dc.subject.mesh | Rats | en_HK |
dc.subject.mesh | Succinate Dehydrogenase - antagonists & inhibitors - pharmacology | en_HK |
dc.title | Chloramphenicol succinate, a competitive substrate and inhibitor of succinate dehydrogenase: Possible reason for its toxicity | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Cheung, BMY:mycheung@hku.hk | en_HK |
dc.identifier.email | Chan, LC:chanlc@hkucc.hku.hk | en_HK |
dc.identifier.email | Liang, R:rliang@hku.hk | en_HK |
dc.identifier.authority | Cheung, BMY=rp01321 | en_HK |
dc.identifier.authority | Chan, LC=rp00373 | en_HK |
dc.identifier.authority | Liang, R=rp00345 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1016/j.tiv.2003.12.010 | en_HK |
dc.identifier.pmid | 15130601 | - |
dc.identifier.scopus | eid_2-s2.0-2342593351 | en_HK |
dc.identifier.hkuros | 87678 | - |
dc.identifier.hkuros | 101472 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-2342593351&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 18 | en_HK |
dc.identifier.issue | 4 | en_HK |
dc.identifier.spage | 441 | en_HK |
dc.identifier.epage | 447 | en_HK |
dc.identifier.isi | WOS:000222155000006 | - |
dc.publisher.place | United Kingdom | en_HK |
dc.identifier.scopusauthorid | Ambekar, CS=55278609200 | en_HK |
dc.identifier.scopusauthorid | Lee, JSK=7601479992 | en_HK |
dc.identifier.scopusauthorid | Cheung, BMY=7103294806 | en_HK |
dc.identifier.scopusauthorid | Chan, LC=7403540707 | en_HK |
dc.identifier.scopusauthorid | Liang, R=26643224900 | en_HK |
dc.identifier.scopusauthorid | Kumana, CR=7005112381 | en_HK |
dc.identifier.issnl | 0887-2333 | - |